Sequenta - Crunchbase Company Profile & Funding

Q: Who invested in Sequenta?

Sequenta has 6 investors including Celgene And Index Ventures.

Q: When was the last funding round for Sequenta?

Sequenta closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Sequenta raised to date?

Sequenta has raised obfuscated.

Overview

Sequenta

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Sequenta

CB Rank

374074

Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.

Acquired by

Adaptive Biotechnologies

Founded

obfuscation

Private

Venture - Series Unknown

San Francisco, California, United States

51-100

www.sequenta.com/

Biotechnology

Health Diagnostics

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

SEQUENTA, INC.

Operating Status

Active

Company Type

For Profit

Founders

Malek Faham, Tom Willis

About the Company

Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human

genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay.

The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.

Phone Number

650-243-3900

Contact Email

tom.willis@mlcdx.com

Predictions & Insights

Growth Insight

See this Growth Insight

Sequenta is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

clonoSEQ

A diagnostic test for detecting and monitoring minimal residual disease (MRD) in patients with multiple myeloma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia.

immunoSEQ

A research tool that profiles and monitors the adaptive immune response by sequencing T-cell and B-cell receptors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Sequenta	1	obfuscated obfuscation	Celgene	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Celgene	Yes	Venture Round - Sequenta	—
Celgene	Yes	Venture Round - Sequenta	—
Celgene	Yes	Venture Round - Sequenta	—
Celgene	Yes	Venture Round - Sequenta	—
Celgene	Yes	Venture Round - Sequenta	—